The Effect of Nebulized Furosemide in Patients with Acute Cardiogenic Pulmonary Edema: A Randomized Clinical Trial | Zendy

Babak Mahshidfar | Zendy; Reza Mosaddegh | Zendy; Mehdi Rezaee | Zendy; AmirSadegh Alimardani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Effect of Nebulized Furosemide in Patients with Acute Cardiogenic Pulmonary Edema: A Randomized Clinical Trial

Author(s) -

Babak Mahshidfar,

Reza Mosaddegh,

Mehdi Rezaee,

AmirSadegh Alimardani

Publication year - 2018

Publication title -

qom univ med sci j

Language(s) - English

Resource type - Journals

eISSN - 2008-1375

pISSN - 1735-7799

DOI - 10.29252/qums.12.10.1

Subject(s) - furosemide , medicine , randomized controlled trial , pulmonary edema , acute decompensated heart failure , anesthesia , edema , clinical trial , acute pulmonary edema , cardiology , heart failure , lung

Accepted: 25 Jul, 2018 Abstract Background and Objectives: Furosemide is one of the elements of drug therapy for cardiogenic pulmonary edema, but its systemic administration is associated with complications, such as hypotension, renal damage, and decreased serum potassium. Inhalation administration is a new route, which does not have the side effects of systemic administration, but its effectiveness is still unclear. The aim of this study was to determine the effectiveness of treatment with the nebulized furosemide in patients with acute cardiogenic pulmonary edema

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research